APA (7th ed.) Citation

M, V., CR, F., A, V., EY, Z., T, F., L, Z., . . . MD, H. (2020). Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis. Frontiers in oncology, 10, 442. https://doi.org/10.3389/fonc.2020.00442

Chicago Style (17th ed.) Citation

M, Vanneste, et al. "Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis." Frontiers in Oncology 10 (2020): 442. https://doi.org/10.3389/fonc.2020.00442.

MLA (9th ed.) Citation

M, Vanneste, et al. "Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis." Frontiers in Oncology, vol. 10, 2020, p. 442, https://doi.org/10.3389/fonc.2020.00442.